Anticancer Activities and Mechanism of Action of Nagilactones, a Group of Terpenoid Lactones Isolated from Podocarpus Species

doi:10.1007/s13659-020-00268-8

摘要/Abstract

摘要： Nagilactones are tetracyclic natural products isolated from various Podocarpus species. These lactone-based compounds display a range of pharmacological effects, including antifungal, anti-atherosclerosis, anti-inflammatory and anticancer activities reviewed here. The most active derivatives, such as nagilactones C, E and F, exhibit potent anticancer activities against different cancer cell lines and tumor models. A comprehensive analysis of their mechanism of action indicates that their anticancer activity mainly derives from three complementary action:(i) a drug-induced inhibition of cell proliferation coupled with a cell cycle perturbation and induction of apoptosis, (ii) a blockade of the epithelial to mesenchymal cell transition contributing to an inhibition of cancer cell migration and invasion and (iii) a capacity to modulate the PD-L1 immune checkpoint. Different molecular effectors have been implicated in the antitumor activity, chiefly the AP-1 pathway blocked upon activation of the JNK/c-Jun axis. Nag-C is a potent inhibitor of protein synthesis binding to eukaryotic ribosomes and inhibition of different protein kinases, such as RIOK2 and JAK2, has been postulated with Nag-E. The literature survey on nagilactones highlights the therapeutic potential of these little-known terpenoids. The mechanistic analysis also provides useful information for structurally related compounds (podolactones, oidiolactones, inumakilactones) isolated from Podocarpus plants.

关键词: Cancer, Natural products, Mechanism of action, Molecular target, Terpenoids

Abstract: Nagilactones are tetracyclic natural products isolated from various Podocarpus species. These lactone-based compounds display a range of pharmacological effects, including antifungal, anti-atherosclerosis, anti-inflammatory and anticancer activities reviewed here. The most active derivatives, such as nagilactones C, E and F, exhibit potent anticancer activities against different cancer cell lines and tumor models. A comprehensive analysis of their mechanism of action indicates that their anticancer activity mainly derives from three complementary action:(i) a drug-induced inhibition of cell proliferation coupled with a cell cycle perturbation and induction of apoptosis, (ii) a blockade of the epithelial to mesenchymal cell transition contributing to an inhibition of cancer cell migration and invasion and (iii) a capacity to modulate the PD-L1 immune checkpoint. Different molecular effectors have been implicated in the antitumor activity, chiefly the AP-1 pathway blocked upon activation of the JNK/c-Jun axis. Nag-C is a potent inhibitor of protein synthesis binding to eukaryotic ribosomes and inhibition of different protein kinases, such as RIOK2 and JAK2, has been postulated with Nag-E. The literature survey on nagilactones highlights the therapeutic potential of these little-known terpenoids. The mechanistic analysis also provides useful information for structurally related compounds (podolactones, oidiolactones, inumakilactones) isolated from Podocarpus plants.

Key words: Cancer, Natural products, Mechanism of action, Molecular target, Terpenoids

Christian Bailly. Anticancer Activities and Mechanism of Action of Nagilactones, a Group of Terpenoid Lactones Isolated from Podocarpus Species[J]. 应用天然产物, 2020, 10(6): 367-375.

Christian Bailly. Anticancer Activities and Mechanism of Action of Nagilactones, a Group of Terpenoid Lactones Isolated from Podocarpus Species[J]. Natural Products and Bioprospecting, 2020, 10(6): 367-375.

参考文献

1. Y. Hayashi, S. Takahashi, H. Ona, T. Sakan, Tetrahedron Lett. 17, 2071-2076 (1968)
2. Y. Hayashi, J. Yokoi, Y. Watanabe, T. Sakan, Chem Lett. 1(9), 759-762 (1972)
3. D.P. Little, P. Knopf, C. Schulz, PLoS ONE 8, e81008 (2013)
4. G.B. Russell, P.G. Fenemore, P. Singh, Aust. J. Biol. Sci. 25, 1025-1029 (1972)
5. B.P. Ying, I. Kubo, Phytochemistry 34, 1107-1110 (1993)
6. K. Shrestha, A.H. Banskota, S. Kodata, S.P. Shrivastava, G. Strobel, M.B. Gewali, Phytomedicine 8, 489-491 (2001)
7. Y.J. Kuo, S.Y. Hwang, M.D. Wu, C.C. Liao, Y.H. Liang, Y.H. Kuo, H.O. Ho, Chem. Pharm. Bull. (Tokyo) 56, 585-588 (2008)
8. H.S. Abdillahi, G.I. Stafford, J.F. Finnie, J. Van Staden, S. Afr. J. Bot. 76, 1-24 (2010)
9. L.C. Zhang, X.D. Wu, J. He, Y. Li, R.P. Zhang, Q.S. Zhao, Phytochem. Lett. 6, 364-367 (2013)
10. E.M. Addo, H.B. Chai, A. Hymete, M.Y. Yeshak, C. Slebodnick, D.G. Kingston, L.H. Rakotondraibe, J. Nat. Prod. 78, 827-835 (2015)
11. Y.D. Zheng, X.C. Guan, D. Li, A.Q. Wang, C.Q. Ke, C.P. Tang, L.G. Lin, Y. Ye, Z.L. Wang, S. Yao, Molecules 21, 1282 (2016)
12. H. Zhao, H. Li, G. Huang, Y. Chen, Nat. Prod. Res. 31, 844-848 (2017)
13. L.J. Xuan, Y.M. Xu, S.D. Fang, Phytochemistry 39, 1143-1145 (1995)
14. L. Faiella, A. Temraz, N. De Tommasi, A. Braca, Phytochemistry 76, 172-177 (2012)
15. Y.D. Zheng, G. Bai, C. Tang, C.Q. Ke, S. Yao, L.J. Tong, F. Feng, Y. Li, J. Ding, H. Xie, Y. Ye, Fitoterapia 125, 174-183 (2018)
16. Y. Hayashi, T. Matsumoto, J. Org. Chem. 47, 3421-3428 (1982)
17. A.F. Barrero, Q. Del Moral, M. Marherrador, Stud. Nat. Prod. Chem. 28, 453-516 (2003)
18. I. Kubo, B.P. Ying, Phytochemistry 1991(30), 3476-3477 (1991)
19. Y. Ohmae, K. Shibata, T. Yamakura, J. Chem. Ecol. 22, 477-489 (1996)
20. I. Kubo, T. Matsumoto, J.A. Klocke, J. Chem. Ecol. 10, 547-559 (1984)
21. H. Yasui, J. Chem. Ecol. 27, 1345-1353 (2001)
22. P. Singh, P.G. Fenemore, G.B. Russell, Aust. J. Biol. Sci. 26, 911-915 (1973)
23. P. Singh, G.B. Russell, Y. Hayashi, R.T. Gallagher, S. Fredericksen, Entomol. Exp. Appl. 25, 121-127 (1979)
24. I. Kubo, H. Muroi, M. Himejima, J. Nat. Prod. 56, 220-226 (1993)
25. Y. Hayashi, T. Sakan, Gan 66, 587-588 (1975)
26. Y.Y. Qi, J. Su, Z.J. Zhang, L.W. Li, M. Fan, Y. Zhu, X.D. Wu, Q.S. Zhao, Chem. Biodivers. 15, e1800043 (2018)
27. S.Y. Huang, L.Y. Fan, Y.C. Shen, C.C. Liao, L.C. Hsu, Y.W. Hsu, T.S. Wu, P.C. Hsiao, C.C. Shen, M.J. Don, Y.H. Kuo, J. Asian Nat. Prod. Res. 11, 410-416 (2009)
28. Z.L. Feng, L.L. Zhang, Y.D. Zheng, Q.Y. Liu, J.X. Liu, L. Feng, L. Huang, Q.W. Zhang, J.J. Lu, L.G. Lin, J. Nat. Prod. 80, 2110-2117 (2017)
29. K. Sato, Y. Inaba, H.S. Park, T. Akiyama, T. Koyama, H. Fukaya, Y. Aoyagi, K. Takeya, Chem. Pharm. Bull. (Tokyo) 57, 668-679 (2009)
30. L.L. Zhang, Z.L. Feng, M.X. Su, X.M. Jiang, X. Chen, Y. Wang, A. Li, L.G. Lin, J.J. Lu, Eur. J. Pharmacol. 830, 17-25 (2018)
31. H. Shan, S. Yao, Y. Ye, Q. Yu, Acta Pharmacol. Sin. 40, 1578-1586 (2019)
32. P.A. Benatrehina, W.L. Chen, A.A. Czarnecki, S. Kurina, H.B. Chai, D.D. Lantvit, T.N. Ninh, X. Zhang, D.D. Soejarto, J.E. Burdette, A.D. Kinghorn, L.H. Rakotondraibe, Nat. Prod. Bioprospect. 9, 157-163 (2019)
33. L.L. Zhang, J. Guo, X.M. Jiang, X.P. Chen, Y.T. Wang, A. Li, L.G. Lin, H. Li, J.J. Lu, Acta Pharmacol. Sin. 41, 698-705 (2020)
34. K. Hayashi, Y. Yamaguchi, A. Ogita, T. Tanaka, I. Kubo, K.I. Fujita, Fitoterapia 128, 112-117 (2018)
35. K. Fujita, M. Tatsumi, A. Ogita, I. Kubo, T. Tanaka, FEBS J. 281, 1304-1313 (2014)
36. K.I. Fujita, T. Ishikura, Y. Jono, Y. Yamaguchi, A. Ogita, I. Kubo, T. Tanaka, Biochim. Biophys. Acta Gen. Subj. 1861, 477-484 (2017)
37. Z.L. Feng, T. Zhang, J.X. Liu, X.P. Chen, L.S. Gan, Y. Ye, L.G. Lin, J. Nat. Med. 72, 882-889 (2018)
38. S.J. Chen, W.C. Huang, T.T. Yang, J.H. Lu, L.T. Chuang, Food Chem. Toxicol. 50, 3687-3695 (2012)
39. Y. Gui, S. Yao, H. Yan, L. Hu, C. Yu, F. Gao, C. Xi, H. Li, Y. Ye, Y. Wang, Cardiovasc. Res. 112, 502-514 (2016)
40. A. Li, X. Xiao, Z.L. Feng, X. Chen, L.J. Liu, L.G. Lin, J.J. Lu, L.L. Zhang, Toxicol. Appl. Pharmacol. 389, 114882 (2020)
41. Y. Sun, X. Jiang, Y. Lu, J. Zhu, L. Yu, B. Ma, Q. Zhang, Chem. Biol. Interact. 296, 57-64 (2018)
42. C.S. Cheng, J.X. Chen, J. Tang, Y.W. Geng, L. Zheng, L.L. Lv, L.Y. Chen, Z. Chen, Cancer Manag. Res. 12, 641-651 (2020)
43. L.L. Zhang, X.M. Jiang, M.Y. Huang, Z.L. Feng, X. Chen, Y. Wang, H. Li, A. Li, L.G. Lin, J.J. Lu, Phytomedicine 52, 32-39 (2019)
44. K.P. Devkota, R. Ratnayake, N.H. Colburn, J.A. Wilson, C.J. Henrich, J.B. McMahon, J.A. Beutler, J. Nat. Prod. 74, 374-377 (2011)
45. S. Trop-Steinberg, Y. Azar, Am. J. Med. Sci. 353, 474-483 (2017)
46. V. Atsaves, V. Leventaki, G.Z. Rassidakis, Cancers (Basel) 11, 1037 (2019)
47. Y.C. Chen, M.Y. Huang, L.L. Zhang, Z.L. Feng, X.M. Jiang, L.W. Yuan, R.Y. Huang, B. Liu, H. Yu, Y.T. Wang, X.P. Chen, L.G. Lin, J.J. Lu, Chin. J. Nat. Med. 18, 517-525 (2020)
48. H.R. Zhou, K. He, J. Landgraf, X. Pan, J.J. Pestka, Toxins (Basel) 6, 3406-3425 (2014)
49. J. Chan, S.N. Khan, I. Harvey, W. Merrick, J. Pelletier, RNA 10, 528-543 (2004)
50. N. Garreau de Loubresse, I. Prokhorova, W. Holtkamp, M.V. Rodnina, G. Yusupova, M. Yusupov, Nature 513, 517-522 (2014)
51. J. Wang, T. Varin, M. Vieth, J.M. Elkins, Open Biol. 9, 190037 (2019)
52. F. Maurice, N. Pérébaskine, S. Thore, S. Fribourg, RNA Biol. 16, 1633-1642 (2019)
53. Y. Song, C. Li, L. Jin, J. Xing, Z. Sha, T. Zhang, D. Ji, R. Yu, S. Gao, J. Cell. Mol. Med. 24, 4494-4509 (2020)
54. B.E. Campbell, P.R. Boag, A. Hofmann, C. Cantacessi, C.K. Wang, P. Taylor, M. Hu, Z.U. Sindhu, A. Loukas, P.W. Sternberg, R.B. Gasser, Biotechnol. Adv. 29, 338-350 (2011)
55. H. Zhou, T. Zhou, B. Zhang, W. Lei, W. Yuan, J. Shan, Y. Zhang, N. Gupta, M. Hu, Int. J. Parasitol 50, 595-602 (2020)
56. H. Cai, X. Qin, C. Yang, J. Cell. Biochem. 118, 3381-3390 (2017)
57. N.H. Thoennissen, G.B. Iwanski, N.B. Doan, R. Okamoto, P. Lin, S. Abbassi, J.H. Song, D. Yin, M. Toh, W.D. Xie, J.W. Said, H.P. Koeffler, Cancer Res. 69, 5876-5884 (2009)
58. Q. Zheng, Y. Liu, W. Liu, F. Ma, Y. Zhou, M. Chen, J. Chang, Y. Wang, G. Yang, G. He, Mol. Med. Rep. 10, 89-94 (2014)
59. S. Liu, S. Chen, J. Zeng, Mol. Med. Rep. 17, 699-704 (2018)
60. Global Biodiversity Information Facility (GBIF). https://www.gbif.org/fr/species/2687779. Accessed 9 Aug 2020
61. Y. Yang, J. Yong, C. Lu, Biomed. Res. Rev. 2, 1-5 (2018)
62. Y. Hayashi, T. Matsumoto, T. Hyono, N. Nishikawa, M. Uemura, M. Nishizawa, M. Togami, T. Sakan, Tetrahedron Lett. 1979(35), 3311-3314 (1979)
63. S.D. Burke, M.E. Kort, S.M.S. Strickland, H.M. Organ, L.A. Silks Ⅲ, Tetrahedron Lett. 35, 1503-1506 (1994)
64. S. Hanessian, N. Boyer, G.J. Reddy, B. Deschênes-Simard, Org. Lett. 11, 4640-4643 (2009)
65. E. Lautié, O. Russo, P. Ducrot, J.A. Boutin, Front. Pharmacol. 11, 397 (2020)
66. N. Ye, Y. Ding, C. Wild, Q. Shen, J. Zhou, J. Med. Chem. 57, 6930-6948 (2014)
67. E.F. Gilman, D.G. Watson, University of Florida, IFAS extension #ENH656. https://edis.ifas.ufl.edu/st497. Accessed 7 Aug 2020.
68. Y. Hayashi, T. Matsumoto, M. Uemura, M. Koreeda, Org. Magn. Res. 14, 86-91 (1980)
69. Y. Hayashi, T. Matsumoto, M. Nishizawa, M. Togami, T. Hyono, N. Nishikawa, M. Uemura, T. Sakan, J. Org. Chem. 47, 3428-3433 (1982)
70. J.A. Hembree, C.J. Chang, J.M. McLaughlin, J.M. Cassady, D.J. Watts, E. Wenkert, S.F. Fonseca, J.D.P. Campello, Phytochemistry 18, 1691-1694 (1979)

[1]	Patricia Quintero-Rincón, Karina Caballero-Gallardo, Jesus Olivero-Verbel. Natural anticancer agents: prospection of medicinal and aromatic plants in modern chemoprevention and chemotherapy[J]. 应用天然产物, 2025, 15(3): 25-25.
[2]	Hesham R. El-Seedi, Mohamed S. Refaey, Nizar Elias, Mohamed F. El-Mallah, Faisal M. K. Albaqami, Ismail Dergaa, Ming Du, Mohamed F. Salem, Haroon Elrasheid Tahir, Maria Dagliaa, Nermeen Yosri, Hongcheng Zhang, Awg H. El-Seedi, Zhiming Guo, Shaden A. M. Khalifa. Marine natural products as a source of novel anticancer drugs: an updated review (2019-2023)[J]. 应用天然产物, 2025, 15(2): 13-13.
[3]	María I. Osella, Mario O. Salazar, Carlos M. Solís, Ricardo L. E. Furlan. New semisynthetic α-glucosidase inhibitor from a doubly-chemically engineered extract[J]. 应用天然产物, 2025, 15(1): 4-4.
[4]	Ahmed H. Elbanna, Xinhui Kou, Dilip V. Prajapati, Surasree Rakshit, Rebecca A. Butcher. Discovery of a parallel family of euglenatide analogs in Euglena gracilis[J]. 应用天然产物, 2025, 15(1): 10-10.
[5]	Phanruethai Pailee, Paratchata Batsomboon, Wiriya Yaosanit, Theerawat Thananthaisong, Chulabhorn Mahidol, Poonsakdi Ploypradith, Nanthawan Reuk-ngam, Panita Khlaychan, Supanna Techasakul, Somsak Ruchirawat, Vilailak Prachyawarakorn. Grewiifopenes A-K, bioactive clerodane diterpenoids from Casearia grewiifolia Vent.[J]. 应用天然产物, 2024, 14(6): 54-54.
[6]	Lu Cao, Jun-Feng Tan, Zeng-Guang Zhang, Jun-Wei Yang, Yu Mu, Zhi-Long Zhao, Yi Jiang, Xue-Shi Huang, Li Han. Discovery of structurally diverse sesquiterpenoids from Streptomyces fulvorobeus isolated from Elephas maximus feces and their antifungal activities[J]. 应用天然产物, 2024, 14(6): 61-61.
[7]	Yu Chen, Qin Li, Yongqi Li, Wenyi Zhang, Yu Liang, Aimin Fu, Mengsha Wei, Weiguang Sun, Chunmei Chen, Yonghui Zhang, Hucheng Zhu. Quadriliterpenoids A-I, nine new 4,4-dimethylergostane and oleanane triterpenoids from Aspergillus quadrilineatus with immunosuppressive inhibitory activity[J]. 应用天然产物, 2024, 14(6): 59-59.
[8]	Song-Yu Hou, Bing-Chao Yan, Han-Dong Sun, Pema-Tenzin Puno. Recent advances in the application of [2+2] cycloaddition in the chemical synthesis of cyclobutane-containing natural products[J]. 应用天然产物, 2024, 14(5): 37-37.
[9]	Felaine Anne Sumang, Alan Ward, Jeff Errington, Yousef Dashti. Hibiscus acid and hydroxycitric acid dimethyl esters from Hibiscus flowers induce production of dithiolopyrrolone antibiotics by Streptomyces Strain MBN2-2[J]. 应用天然产物, 2024, 14(5): 40-40.
[10]	Antonio Evidente. Advances on anticancer fungal metabolites: sources, chemical and biological activities in the last decade (2012-2023)[J]. 应用天然产物, 2024, 14(4): 31-31.
[11]	Chunsong Hu. Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease[J]. 应用天然产物, 2024, 14(2): 2-2.
[12]	Guifeng Su, Dan Wang, Qianqing Yang, Lingmei Kong, Xiaoman Ju, Qihong Yang, Yiying Zhu, Shaohua Zhang, Yan Li. Cepharanthine suppresses APC-mutant colorectal cancers by down-regulating the expression of β-catenin[J]. 应用天然产物, 2024, 14(2): 6-6.
[13]	Shiyun Nie, Lizhong Chang, Ying Huang, Heyang Zhou, Qianqing Yang, Lingmei Kong, Yan Li. β-carboline derivative Z86 attenuates colorectal cancer cell proliferation and migration by directly targeting PI3K[J]. 应用天然产物, 2024, 14(1): 3-3.
[14]	Shohreh Ariaeenejad, Javad Gharechahi, Mehdi Foroozandeh Shahraki, Fereshteh Fallah Atanaki, Jian-Lin Han, Xue-Zhi Ding, Falk Hildebrand, Mohammad Bahram, Kaveh Kavousi, Ghasem Hosseini Salekdeh. Precision enzyme discovery through targeted mining of metagenomic data[J]. 应用天然产物, 2024, 14(1): 7-7.
[15]	Yin-Zhong Fan, Chun Tian, Shun-Yao Tong, Qing Liu, Fan Xu, Bao-Bao Shi, Hong-Lian Ai, Ji-Kai Liu. The antifungal properties of terpenoids from the endophytic fungus Bipolaris eleusines[J]. 应用天然产物, 2023, 13(6): 43-43.